Slow-wave sleep and daytime functioning in chronic fatigue syndrome: effects of sodium oxybate - SWS And daytime Functioning in chronic FatiguE syndrome (SAFFE)

Imperial College0 个研究点开始时间: 2013年9月19日最近更新: 2013年9月23日

适应症

试验速览

暂无简介。

•Meeting criteria for CFS according to both the revised CDC and Canadian diagnostic systems
•Aged 25-65
•Good grasp of the English language
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 12
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range 0

•Taking medication which interferes with sodium oxybate metabolism including tramadol, phenytoin, valproate, or medication that would interfere with sleep including benzodiazepines, Z hypnotics, antidepressant except <30mg amitryptyline
•Current major psychiatric disorder
•Unusual sleep schedule (bedtime routines that fall outside 9 p.m. to 10 a.m.; usual time in bed >12 hours)
•Pregnancy, lactation or being female and not using reliable contraception
•Relevant abnormal clinical findings at screening visit

发起方

Imperial College